UNSPSC 51192016: Thiopurinol or tisopurine

This classification denotes a xanthine oxidase inhibitor and uricosuric agent with the molecular formula C5H4N4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 79F9I2R16M, chemically known as 5h-pyrazolo(3,4-d)pyrimidine-4-thione but generally known as tisopurine, which bears US NIH Compound Identifier 667510. European Medicines Agency schedules Tisopurine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11121MIG.

UNSPSC 51192016 Thiopurinol or tisopurine is a Commodity code with no relevant recent state and local procurement activity. The three most recent opportunities tagged under this code—athletic training services for fire and police departments (City of Tucson, RFP), medical aid supplies for fire rescue (City of Tampa, ITB), and a therapeutic pharmacy initiative information request (Texas HHS Commission, RFI)—do not involve procurement of thiopurinol or tisopurine, a xanthine oxidase inhibitor used in the treatment of gout and related uric acid disorders. The code's nominal scope and the work actually being solicited under it do not align.

State and local governments show no current demand signal for thiopurinol or tisopurine through recent competitive solicitations, and the available opportunities do not support characterization of issuing-body mix, geographic spread, or market activity for this pharmaceutical commodity. The mismatch between the code's pharmaceutical classification and the health services and general medical supplies being sought in recent notices suggests either tagging error or minimal procurement volume in the state and local space for this specific compound.